SCHEMBL1673252

SCHEMBL1673252

Cc1ccc(S(=O)(=O)n2ccc3ccccc32)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 8/20 0.75
HTT P42858 4/20 0.75
MEN1 O00255 3/20 0.75
KMT2A Q03164 3/20 0.75
ALDH1A1 P00352 1/20 0.75
LMNA P02545 1/20 0.75
HPGD P15428 1/20 0.75
TSHR P16473 1/20 0.75
L3MBTL1 Q9Y468 5/20 0.71
PKM P14618 1/20 0.71
MAPT P10636 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
RAPGEF4 Q8WZA2 1/20 0.68
TDP1 Q9NUW8 1/20 0.68
POLB P06746 2/20 0.55
ALDH3A1 P30838 2/20 0.55
NOD1 Q9Y239 1/20 0.55
KDM4E B2RXH2 1/20 0.52
UBE2N P61088 1/20 0.52
CA1 P00915 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414854 1.00 HTR6 (0.75) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL1203289 0.98 HTR6 (0.73) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL429849 0.86 HTR6 (1.00) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL29558135 0.86 HTR6 (1.00) HTR6HTTMEN1KMT2AALDH1A1
Ethoxycarbonyl Group SCHEMBL28073916 0.85 HTR6 (0.56) HTR6HTTMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL28794299 0.84 HTR6 (0.96) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL1898211 0.83 HTR6 (0.56) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL9587047 0.83 HTR6 (0.75) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL31663420 0.83 HTR6 (0.81) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL1894102 0.83 HTR6 (0.61) HTR6HTTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6033601-A POLYMERIZED FROM A 1-SUBSTITUTED, 3-SUBSTITUTED OR 1,3-SUBSTITUTED INDOLE MONOMER AND A GAS SENSOR CONTAINING THIS POLYMER AS THE ACTIVE GAS SENSING ELEMENT. AROMASCAN PLC (GB) 2000-03-07 US claimed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
CN-113880815-B Indole derivatives, preparation method and application thereof 中国药科大学 2024-03-29 CN disclosed
CN-114133394-B Compound selectively aiming at activity of cell cycle dependent kinase 12, preparation method and medical application 赛诺哈勃药业(成都)有限公司 2023-12-08 CN disclosed
CN-115353478-B Preparation method of indole compound 南京工业大学 2023-10-27 CN disclosed
CN-111170924-B Method for electrochemically synthesizing hexafluoroisopropoxyindole compound 广西师范大学 2023-06-30 CN disclosed
CN-115353478-A Preparation method of indole compound 南京工业大学 2022-11-18 CN disclosed
CN-111763148-B Alkynyl cyclopentene derivative containing trifluoromethyl and preparation method and application thereof 广州大学 2022-10-28 CN disclosed
US-11479867-B2 Electrocatalytic alkene diazidation CORNELL UNIVERSITY (US) 2022-10-25 US disclosed
CN-1717233-A 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents CANCER REC TECH LTD (GB) 2006-01-04 CN disclosed
US-20050020583-A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them PFIZER ITALIA S.R.L. (IT) 2005-01-27 US disclosed
US-6033601-A POLYMERIZED FROM A 1-SUBSTITUTED, 3-SUBSTITUTED OR 1,3-SUBSTITUTED INDOLE MONOMER AND A GAS SENSOR CONTAINING THIS POLYMER AS THE ACTIVE GAS SENSING ELEMENT. AROMASCAN PLC (GB) 2000-03-07 US disclosed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0797769-A1 SEMICONDUCTING ORGANIC POLYMERS AROMASCAN PLC (GB) 1997-10-01 EP disclosed
WO-1996018888-A1 SEMICONDUCTING ORGANIC POLYMERS AROMASCAN PLC (GB) 1996-06-20 WO disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed
WO-1993013079-A1 ANTIFOLATE QUINAZOLINES AGOURON PHARMACEUTICALS, INC. (US) 1993-07-08 WO disclosed
CN-1056497-A Indolone and relevant derivative with neuroprotective PFIZER (US) 1991-11-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 HTR6 4706/4885HTT 3039/4885MEN1 2402/4885
US-20050020583-A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them MAP3K20, MAP3K1, MAP3K15 HTR6 3344/4885HTT 1001/4885MEN1 1149/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 HTR6 4706/4885HTT 3039/4885MEN1 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.